These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 32473861)
21. Quantitative Expression of Hepatobiliary Transporters and Functional Uptake of Substrates in Hepatic Two-Dimensional Sandwich Cultures: A Comparative Evaluation of Upcyte and Primary Human Hepatocytes. Schaefer M; Morinaga G; Matsui A; Schänzle G; Bischoff D; Süssmuth RD Drug Metab Dispos; 2018 Feb; 46(2):166-177. PubMed ID: 29212823 [TBL] [Abstract][Full Text] [Related]
22. Ochratoxin A transport by the human breast cancer resistance protein (BCRP), multidrug resistance protein 2 (MRP2), and organic anion-transporting polypeptides 1A2, 1B1 and 2B1. Qi X; Wagenaar E; Xu W; Huang K; Schinkel AH Toxicol Appl Pharmacol; 2017 Aug; 329():18-25. PubMed ID: 28532671 [TBL] [Abstract][Full Text] [Related]
23. Results From Drug-Drug Interaction Studies In Vitro and In Vivo Investigating the Inhibitory Effect of Finerenone on the Drug Transporters BCRP, OATP1B1, and OATP1B3. Heinig R; Fricke R; Wertz S; Nagelschmitz J; Loewen S Eur J Drug Metab Pharmacokinet; 2022 Nov; 47(6):803-815. PubMed ID: 36029368 [TBL] [Abstract][Full Text] [Related]
24. Regulation of drug transporter expression by oncostatin M in human hepatocytes. Le Vee M; Jouan E; Stieger B; Lecureur V; Fardel O Biochem Pharmacol; 2011 Aug; 82(3):304-11. PubMed ID: 21570956 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of Drug-Drug Interactions of Ensitrelvir, a SARS-CoV-2 3CL Protease Inhibitor, With Transporter Substrates Based on In Vitro and Clinical Studies. Shimizu R; Matsuzaki T; Oka R; Sonoyama T; Fukuhara T; Kuwata A; Matsuo Y; Kubota R J Clin Pharmacol; 2023 Aug; 63(8):918-927. PubMed ID: 37043676 [TBL] [Abstract][Full Text] [Related]
26. Dissecting the Contribution of OATP1B1 to Hepatic Uptake of Statins Using the OATP1B1 Selective Inhibitor Estropipate. Zhang Y; Panfen E; Fancher M; Sinz M; Marathe P; Shen H Mol Pharm; 2019 Jun; 16(6):2342-2353. PubMed ID: 31039308 [TBL] [Abstract][Full Text] [Related]
27. Prediction of organic anion-transporting polypeptide 1B1- and 1B3-mediated hepatic uptake of statins based on transporter protein expression and activity data. Kunze A; Huwyler J; Camenisch G; Poller B Drug Metab Dispos; 2014 Sep; 42(9):1514-21. PubMed ID: 24989890 [TBL] [Abstract][Full Text] [Related]
28. Organic Anion-Transporting Polypeptide and Efflux Transporter-Mediated Hepatic Uptake and Biliary Excretion of Cilostazol and Its Metabolites in Rats and Humans. Wang C; Huo X; Wang C; Meng Q; Liu Z; Sun P; Cang J; Sun H; Liu K J Pharm Sci; 2017 Sep; 106(9):2515-2523. PubMed ID: 28535976 [TBL] [Abstract][Full Text] [Related]
29. Transport mechanisms of hepatic uptake and bile excretion in clinical hepatobiliary scintigraphy with 99mTc-N-pyridoxyl-5-methyltryptophan. Kobayashi M; Nakanishi T; Nishi K; Higaki Y; Okudaira H; Ono M; Tsujiuchi T; Mizutani A; Nishii R; Tamai I; Arano Y; Kawai K Nucl Med Biol; 2014 Apr; 41(4):338-42. PubMed ID: 24607436 [TBL] [Abstract][Full Text] [Related]
30. Role of transporters in the disposition of the selective phosphodiesterase-4 inhibitor (+)-2-[4-({[2-(benzo[1,3]dioxol-5-yloxy)-pyridine-3-carbonyl]-amino}-methyl)-3-fluoro-phenoxy]-propionic acid in rat and human. Kalgutkar AS; Feng B; Nguyen HT; Frederick KS; Campbell SD; Hatch HL; Bi YA; Kazolias DC; Davidson RE; Mireles RJ; Duignan DB; Choo EF; Zhao SX Drug Metab Dispos; 2007 Nov; 35(11):2111-8. PubMed ID: 17686907 [TBL] [Abstract][Full Text] [Related]
31. Characterization of Novel Fluorescent Bile Salt Derivatives for Studying Human Bile Salt and Organic Anion Transporters. Leuenberger M; Häusler S; Höhn V; Euler A; Stieger B; Lochner M J Pharmacol Exp Ther; 2021 Jun; 377(3):346-357. PubMed ID: 33782042 [TBL] [Abstract][Full Text] [Related]
32. Sinusoidal Organic Anion-Transporting Polypeptide 1B1/1B3 and Bile Canalicular Multidrug Resistance-Associated Protein 2 Play an Essential Role in the Hepatobiliary Disposition of a Synthetic Cyclic Dinucleotide (STING Agonist). Sandoval P; Chuang BC; Fallon JK; Smith PC; Chowdhury SK; Griffin RJ; Xia CQ; Iwasaki S; Chothe PP AAPS J; 2022 Sep; 24(6):99. PubMed ID: 36123502 [TBL] [Abstract][Full Text] [Related]
33. Interaction of digitalis-like compounds with liver uptake transporters NTCP, OATP1B1, and OATP1B3. Gozalpour E; Greupink R; Wortelboer HM; Bilos A; Schreurs M; Russel FG; Koenderink JB Mol Pharm; 2014 Jun; 11(6):1844-55. PubMed ID: 24754247 [TBL] [Abstract][Full Text] [Related]
34. Impact of OATP transporters on pharmacokinetics. Kalliokoski A; Niemi M Br J Pharmacol; 2009 Oct; 158(3):693-705. PubMed ID: 19785645 [TBL] [Abstract][Full Text] [Related]
35. Contribution of hepatic organic anion-transporting polypeptides to docetaxel uptake and clearance. Lee HH; Leake BF; Teft W; Tirona RG; Kim RB; Ho RH Mol Cancer Ther; 2015 Apr; 14(4):994-1003. PubMed ID: 25695959 [TBL] [Abstract][Full Text] [Related]
36. Vectorial transport of enalapril by Oatp1a1/Mrp2 and OATP1B1 and OATP1B3/MRP2 in rat and human livers. Liu L; Cui Y; Chung AY; Shitara Y; Sugiyama Y; Keppler D; Pang KS J Pharmacol Exp Ther; 2006 Jul; 318(1):395-402. PubMed ID: 16627748 [TBL] [Abstract][Full Text] [Related]
37. Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology. Andersen V; Svenningsen K; Knudsen LA; Hansen AK; Holmskov U; Stensballe A; Vogel U World J Gastroenterol; 2015 Nov; 21(41):11862-76. PubMed ID: 26557010 [TBL] [Abstract][Full Text] [Related]
38. Human hepatobiliary transport of organic anions analyzed by quadruple-transfected cells. Kopplow K; Letschert K; König J; Walter B; Keppler D Mol Pharmacol; 2005 Oct; 68(4):1031-8. PubMed ID: 16046661 [TBL] [Abstract][Full Text] [Related]
39. Organic anion transporting polypeptides 1B1 and 1B3 play an important role in uremic toxin handling and drug-uremic toxin interactions in the liver. Sato T; Yamaguchi H; Kogawa T; Abe T; Mano N J Pharm Pharm Sci; 2014; 17(4):475-84. PubMed ID: 25579430 [TBL] [Abstract][Full Text] [Related]
40. Octreotide inhibits the bilirubin carriers organic anion transporting polypeptides 1B1 and 1B3 and the multidrug resistance-associated protein 2. Visentin M; Stieger B; Merz M; Kullak-Ublick GA J Pharmacol Exp Ther; 2015 Nov; 355(2):145-51. PubMed ID: 26330539 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]